[{"address1": "4224 Campus Point Court", "address2": "Suite 210", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 202 6300", "website": "https://www.regulusrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph P. Hagan M.B.A.", "age": 55, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 958232, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Crispina  Calsada CPA", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 579300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher Ray Aker J.D.", "age": 63, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 575942, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Preston S. Klassen M.D., M.H.S.", "age": 55, "title": "President, Head of Research & Development and Director", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel J. Penksa", "age": 38, "title": "VP of Finance & Controller", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Claire Susan Padgett M.S., M.T., Ph.D.", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rekha  Garg M.D., M.S.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Lee Ph.D.", "title": "Vice President of Translational Medicine", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 3, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 6, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.38, "open": 1.37, "dayLow": 1.37, "dayHigh": 1.56, "regularMarketPreviousClose": 1.38, "regularMarketOpen": 1.37, "regularMarketDayLow": 1.37, "regularMarketDayHigh": 1.56, "payoutRatio": 0.0, "forwardPE": -1.2231405, "volume": 242534, "regularMarketVolume": 238053, "averageVolume": 487825, "averageVolume10days": 400710, "averageDailyVolume10Day": 400710, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 96940152, "fiftyTwoWeekLow": 0.83, "fiftyTwoWeekHigh": 3.0, "fiftyDayAverage": 1.2972, "twoHundredDayAverage": 1.5976, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 22542208, "profitMargins": 0.0, "floatShares": 48357008, "sharesOutstanding": 65500100, "sharesShort": 2238865, "sharesShortPriorMonth": 1961451, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0342, "heldPercentInsiders": 0.02207, "heldPercentInstitutions": 0.83413005, "shortRatio": 3.07, "shortPercentOfFloat": 0.0434, "impliedSharesOutstanding": 65500100, "bookValue": 1.166, "priceToBook": 1.2692968, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -46358000, "trailingEps": -0.82, "forwardEps": -1.21, "lastSplitFactor": "1:10", "lastSplitDate": 1656460800, "enterpriseToEbitda": -0.454, "52WeekChange": -0.37288135, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 1.48, "targetHighPrice": 28.0, "targetLowPrice": 3.0, "targetMeanPrice": 10.33333, "targetMedianPrice": 7.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 75777000, "totalCashPerShare": 1.144, "ebitda": -49693000, "totalDebt": 274000, "quickRatio": 10.105, "currentRatio": 10.981, "debtToEquity": 0.359, "returnOnAssets": -0.54424, "returnOnEquity": -0.95001, "grossProfits": -35367000, "freeCashflow": -32484750, "operatingCashflow": -41673000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RGLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1741983811, "regularMarketTime": 1741982400, "marketState": "CLOSED", "shortName": "Regulus Therapeutics Inc.", "longName": "Regulus Therapeutics Inc.", "regularMarketPrice": 1.48, "regularMarketChangePercent": 7.246379, "exchange": "NCM", "messageBoardId": "finmb_36742485", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "dividendDate": 1538611200, "earningsTimestamp": 1741896303, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.82, "epsForward": -1.21, "epsCurrentYear": -1.385, "priceEpsCurrentYear": -1.0685921, "fiftyDayAverageChange": 0.18280005, "fiftyDayAverageChangePercent": 0.14091896, "twoHundredDayAverageChange": -0.117599964, "twoHundredDayAverageChangePercent": -0.073610395, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1349789400000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.48, "postMarketChange": 0.0, "regularMarketChange": 0.100000024, "regularMarketDayRange": "1.37 - 1.56", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 487825, "fiftyTwoWeekLowChange": 0.65000004, "fiftyTwoWeekLowChangePercent": 0.7831326, "fiftyTwoWeekRange": "0.83 - 3.0", "fiftyTwoWeekHighChange": -1.52, "fiftyTwoWeekHighChangePercent": -0.50666666, "fiftyTwoWeekChangePercent": -37.288136, "displayName": "Regulus Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]